|
News for: |
|
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
FDA Approval Activities for this Drug…
Foradil Aerolizer (formoterol fumarate inhalation powder),Rx Novartis NDA 20-831 2/16/01 4/24/03 5/15/01 Foradil Indications: for long-term, twice daily (morning and evening) administration in the maintenance treatment of asthma and in the prevention of bronchospasm in adults and children 5 years of age and older with reversibel obstructive airways disease, including patients with symptoms of nocturnal asthma, who requir4e regular treatment with inhaled, short-acting, beta2-agonists. Foradil (Formoterol Fumarate) Aerolizer Inhalation Powder, Novartis NDA 20-831/S005 6/27/03 7/6/03 7/8/03 Foradil (Formoterol Fumarate Inhalation Powder) Aerolizer Novartis NDA 21-279 & 20-831/S002 | Foradil Aerolizer (formoterol fumarate) Inhalation Powder, Novartis Pharma, Labeling Revision | SYMBICORT (budesonide/formoterol fumarate dihydrate) Inhalation Aerosol, AstraZeneca Pharma, Approval | Foradil Certihaler, Novartis Pharma, Approval
|